Result Page 108 for Cancer news & latest pictures from ibtimes.com

GTX's Prostate Cancer Treatment Will Complete Efficacy Analysis

GTx Inc. said on Friday its prostate cancer treatment will continue the late stage of its clinical trial as it did not bear the results that were expected. Shares of the company slumped.

Genentech Advances Avastin Trial in Colon Cancer Patients

Genentech Inc., the developer and maker of pharmaceutical products, said Thursday it expects final results from a clinical trial of a cancer drug Avastin in patients with colon cancer to be done by 2009, a year earlier than it previously forecasted.

Shiny Lip Balms and Glosses Increase Risk of Skin Cancer

Women beware: your shiny lip gloss and lip balm may boost your risk of getting skin cancer.

Pfizer and Avant Join for Brain Cancer Vaccine

Pfizer Inc. will pay Avant Immunotherapeutics's Celldex Therapeutics Inc. unit to acquire the exclusive global license of a brain cancer vaccine treatment which is currently in Phase 2 development, the companies announced late Wednesday.

More news

Study: Vitamin E linked to lung cancer

U.S. study revealed that taking daily supplements of vitamin E during a long-term period can increase cancer risk by 28 percent.

FDA Advisors Reject Genentech's Avastin Drug

Genentech's Avastin cancer drug should be rejected for the use in the United States, advisers said on Wednesday.

Dendreon says breast cancer drug effective in initial study

Dendreon Corp. (Nasdaq: DNDN) said its breast cancer vaccine Neuvenge appeared to be safe, according to results of an initial study.

Antisoma, Novartis drug fails in ovarian cancer

An experimental cancer drug from Britain's Antisoma Plc and Swiss-based Novartis AG has failed in a mid-stage clinical trial for ovarian cancer, lopping 15 percent off Antisoma's market value.

Dendreon Skyrockets After Favorable FDA Ruling

The Food and Drug Administration said on Thursday that Dendreon's (Nasdaq: DNDN) prostate cancer treatment was safe and effective, sending shares skyrocketing on Friday trading.

Nuvelo Rallies on Drug's â€˜Fast-Track' Status

Shares of Nuvelo, Inc. (Nasdaq: NUVO) skyrocketed on Tuesday following news that drug maker's cancer drug was granted 'fast-track' status by the U.S. Food and Drug Administration.